27 results on '"Barugel M"'
Search Results
2. P-127 Pathological versus clinical complete responders after preoperative treatment in rectal cancer: long term outcomes analysis
3. Panitumumab with FOLFOX4 versus FOLFOX4 alone as first-line treatment for metastatic colorectal cancer (mCRC): results from the randomised phase III PRIME study: PO349
4. Oxaliplatin (OXA) with weekly bolus 5-fluorouracil (FU) and low-dose leucovorin (ld-LV) in advanced colorectal cancer (ACRC) patients (pts): Report of safety and efficacy: 3769
5. Randomized phase III study of panitumumab (pmab) with FOLFOX4 compared with FOLFOX4 alone as first line treatment (tx) for metastatic colorectal cancer (mCRC): Results by Eastern Cooperative Oncology Group (ECOG) performance status (PS).
6. Final results from PRIME: Randomized phase III study of panitumumab (pmab) with FOLFOX4 for first line metastatic colorectal cancer (mCRC).
7. Phase III study (PRIME/20050203) of panitumumab (pmab) with FOLFOX compared with FOLFOX alone in patients (pts) with previously untreated metastatic colorectal cancer (mCRC): Pooled safety data
8. Neuroendocrine tumors of the gastroenteropancreatic system (NET-GEP). Correlation between Ki-67 immunostaining, histological features and clinical behaviour
9. Oxaliplatin (OXA) with weekly bolus 5-fluorouracil (FU) and low-dose leucovorin (ld-LV) in advanced colorectal cancer (ACRC) patients (pts): Report of safety and efficacy
10. Report of solid cancer in patients (pts) with gastrointestinal stromal tumours (GIST)
11. Microsatellite instability detection in hereditary colorectal cancer: is it possible in a public hospital?
12. Combined intensive chemoradiotherapy for organ preservation in patients with resectable and non-resectable oesophageal cancer
13. Patterns of treatment of pain and other symptoms in cancer patients: A comparison between a North American (NA) and a South American (SA) hospital
14. RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data.
15. Pitfalls in the diagnosis of biallelic PMS2 mutations.
16. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
17. Liver transplant center risk tolerance.
18. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
19. [Prevention of colorectal cancer].
20. [Treatment of patients with squamous cell carcinoma of the anal canal in the last 20 years in a gastroenterology hospital].
21. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
22. [Medical treatment of 44 patients with anal canal carcinoma. Argentinian Intergroup for the treatment of gastrointestinal tumors (IATTGI)].
23. Treatment of pain and other symptoms in cancer patients: patterns in a North American and a South American hospital.
24. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients.
25. [Eosinophilic fasciitis. Case report and review of the literature].
26. Q-T interval prolongation and ventricular fibrillation with i.v. domperidone.
27. Vinca alkaloid-induced cardiovascular autonomic neuropathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.